Kadcyla 100 mg
Kadcyla 100 mg is a medicine authorised by Swissmedic under authorisation number 62892. The authorisation holder is Roche Pharma (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 02 May 2013 and the authorisation is valid without a time limit. ATC code L01FD03 places the medicine in the group Antineoplastic agents.
| Authorisation number | 62892 |
|---|---|
| Name | Kadcyla 100 mg |
| Full name | Kadcyla 100 mg, Pulver zur Herstellung eines Infusionslösungskonzentrates |
| Authorisation holder | Roche Pharma (Schweiz) AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FD03 |
| First authorisation | 02 May 2013 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Kadcyla 100 mg, Pulver zur Herstellung eines Infusionslösungskonzentrates | A | 02 May 2013 |
| 2 | Kadcyla 160 mg, Pulver zur Herstellung eines Infusionslösungskonzentrates | A | 02 May 2013 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01FD03 | 07.16.1. | A |
| 2 | 1 | Durchstechflasche(n) | L01FD03 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Kadcyla 100 mg authorised in Switzerland?
Yes. Kadcyla 100 mg is authorised by Swissmedic under authorisation number 62892, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Kadcyla 100 mg have?
Kadcyla 100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Kadcyla 100 mg?
The authorisation holder is Roche Pharma (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.